Letter : Histological changes among asymptomatic chronic HBV carriers with normal alanine aminotransferase levels
Errataetall: |
CommentOn: Aliment Pharmacol Ther. 2023 Nov;58(10):1041-1051. - PMID 37724651 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:58 |
---|---|
Enthalten in: |
Alimentary pharmacology & therapeutics - 58(2023), 11-12 vom: 01. Dez., Seite 1252-1253 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kountouras, Jannis [VerfasserIn] |
---|
Links: |
---|
Themen: |
Alanine Transaminase |
---|
Anmerkungen: |
Date Completed 22.11.2023 Date Revised 11.12.2023 published: Print CommentOn: Aliment Pharmacol Ther. 2023 Nov;58(10):1041-1051. - PMID 37724651 Citation Status MEDLINE |
---|
doi: |
10.1111/apt.17760 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM364779845 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM364779845 | ||
003 | DE-627 | ||
005 | 20231227132030.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/apt.17760 |2 doi | |
028 | 5 | 2 | |a pubmed24n1226.xml |
035 | |a (DE-627)NLM364779845 | ||
035 | |a (NLM)37986592 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kountouras, Jannis |e verfasserin |4 aut | |
245 | 1 | 0 | |a Letter |b Histological changes among asymptomatic chronic HBV carriers with normal alanine aminotransferase levels |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.11.2023 | ||
500 | |a Date Revised 11.12.2023 | ||
500 | |a published: Print | ||
500 | |a CommentOn: Aliment Pharmacol Ther. 2023 Nov;58(10):1041-1051. - PMID 37724651 | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 4 | |a Comment | |
650 | 7 | |a Alanine Transaminase |2 NLM | |
650 | 7 | |a EC 2.6.1.2 |2 NLM | |
650 | 7 | |a DNA, Viral |2 NLM | |
650 | 7 | |a Hepatitis B e Antigens |2 NLM | |
700 | 1 | |a Kazakos, Evangelos |e verfasserin |4 aut | |
700 | 1 | |a Gatopoulou, Anthia |e verfasserin |4 aut | |
700 | 1 | |a Polyzos, Stergios A |e verfasserin |4 aut | |
700 | 1 | |a Touloumtzi, Maria |e verfasserin |4 aut | |
700 | 1 | |a Kyrailidi, Foteini |e verfasserin |4 aut | |
700 | 1 | |a Mouratidou, Maria C |e verfasserin |4 aut | |
700 | 1 | |a Stogianni, Aggeliki |e verfasserin |4 aut | |
700 | 1 | |a Vardaka, Elisabeth |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Alimentary pharmacology & therapeutics |d 1992 |g 58(2023), 11-12 vom: 01. Dez., Seite 1252-1253 |w (DE-627)NLM012692506 |x 1365-2036 |7 nnns |
773 | 1 | 8 | |g volume:58 |g year:2023 |g number:11-12 |g day:01 |g month:12 |g pages:1252-1253 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/apt.17760 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 58 |j 2023 |e 11-12 |b 01 |c 12 |h 1252-1253 |